Why the study?
Venous to arterial carbon dioxide tension gap has shown prognostic value in non-cardiac surgery, but its prognostic value after cardiopulmonary bypass in cardiac surgery remains controversial.
Does a high Pv-aCO2 gap predict adverse outcomes in adult cardiac surgery patients?
Does a high Pv-aCO2 gap predict adverse outcomes in adult cardiac surgery patients?
Answers are grounded in this paper and cite their sources.
An elevated Pv-aCO2 gap in adult cardiac surgery patients is associated with higher ICU mortality and complications, serving as a potential indicator of tissue hypoperfusion.
Background Cardiac surgery is associated with increased risk of major adverse outcomes. Venous to arterial carbon dioxide tension gap ( Pv-aCO 2 gap) showed significant prognostic value of non-cardiac surgery, while their prognostic value after cardiopulmonary bypass (CPB) remains controversial. Methods We conducted a systematic research of PubMed, MEDLINE, EMBASE and Web of science electronic database and ClinicalTrials.gov to analysis the association between high Pv-aCO 2 gap and adverse outcomes in adult cardiac surgery patients. Random effect model was used to pool data. Results Eight studies ( n = 2136 patients) were enrolled. High Pv-aCO 2 gap was mainly defined as Pv-aCO 2 ≥ 6–8 mmHg. In cardiac surgery, high Pv-aCO 2 gap was not associated with increased hospital mortality (odds ratio, 0.63; 95% CI, 0.17–2.32; p = 0.49)), but was related with higher ICU mortality (odds ratio, 5.27; 95% CI, 2.31–12.00; p < 0.001), higher incidence of major complications ( p < 0.05 ), longer ICU length of stay ( p = 0.03) and prolonged ventilation time in the ICU ( p < 0.001). Moreover, high Pv-aCO 2 gap was linked to postoperative lower cardiac index ( p < 0 .01) and lower ScvO 2 ( p < 0.001). Interesting, high Pv-aCO 2 gap was not associated with increased postoperative lactate level and longer hospital length of stay. Conclusion An elevated Pv-aCO 2 gap seems to be associated with adverse outcomes in very short time and indicates tissue hypoperfusion rather than tissue hypoxia. Therefore, interventions aiming at normalizing Pv-aCO 2 gap may potentially improve clinical outcomes, while further validation is required.
No takes yet. Share an insight, caveat, or question.
Lin et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: